Skip to main content
PMC home page
Infection and Immunity logoLink to Infection and Immunity
. 1979 Jul;25(1):366–375. doi: 10.1128/iai.25.1.366-375.1979

Efficacy of antimicrobial therapy in experimental rat pneumonia: effects of impaired phagocytosis.

I A Bakker-Woudenberg, J Y de Jong-Hoenderop, M F Michel
PMCID: PMC414461  PMID: 478640

Abstract

The importance of intact host defense mechanisms for successful antimicrobial therapy was investigated in an animal model. Recovery from lobar pneumococcal pneumonia as a result of penicillin therapy was studied in normal rats and in rats treated with cobra venom factor. This factor was used to selectively suppress the phagocytosis of pneumococci as a result of complement depletion. Although complete recovery from the infection occurred in normal rats after appropriate penicillin therapy, this was not the case in cobra venom factor-treated rats. Within the limitations of this study, evidence is presented for loss of antibiotic activity as a consequence of impaired phagocytosis.

Full text

PDF
372

Images in this article

369Image
on p.369
370Image
on p.370

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Alper C. A., Abramson N., Johnston R. B., Jr, Jandl J. H., Rosen F. S. Studies in vivo and in vitro on an abnormality in the metabolism of C3 in a patient with increased susceptibility to infection. J Clin Invest. 1970 Nov;49(11):1975–1985. doi: 10.1172/JCI106417. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Alper C. A., Bloch K. J., Rosen F. S. Increased susceptibility to infection in a patient with type II essential hypercatabolism of C3. N Engl J Med. 1973 Mar 22;288(12):601–606. doi: 10.1056/NEJM197303222881204. [DOI] [PubMed] [Google Scholar]
  3. Bakker-Woudenberg I. A., van Gerwen A. L., Michel M. F. Efficacy of antimicrobial therapy in experimental rat pneumonia: antibiotic treatment schedules in rats with impaired phagocytosis. Infect Immun. 1979 Jul;25(1):376–387. doi: 10.1128/iai.25.1.376-387.1979. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Biró L., Iván E. Study of bactericidal and bacteriostatic antibiotics in animals with normal and suppressed immunity. Chemotherapy. 1968;13(2):100–107. doi: 10.1159/000220536. [DOI] [PubMed] [Google Scholar]
  5. Bodey G. P., Buckley M., Sathe Y. S., Freireich E. J. Quantitative relationships between circulating leukocytes and infection in patients with acute leukemia. Ann Intern Med. 1966 Feb;64(2):328–340. doi: 10.7326/0003-4819-64-2-328. [DOI] [PubMed] [Google Scholar]
  6. Bodey G. P., Hersh E. M., Valdivieso M., Feid R., Rodriguez V. Effects of cytotoxic and immunosuppressive agents on the immune system. Postgrad Med. 1975 Dec;58(7):67–74. doi: 10.1080/00325481.1975.11714222. [DOI] [PubMed] [Google Scholar]
  7. Bodey G. P. Infections in cancer patients. Cancer Treat Rev. 1975 Jun;2(2):89–128. doi: 10.1016/s0305-7372(75)80005-3. [DOI] [PubMed] [Google Scholar]
  8. Brown R. S., Haynes H. A., Foley H. T., Godwin H. A., Berard C. W., Carbone P. P. Hodgkin's disease. Immunologic, clinical, and histologic features of 50 untreated patients. Ann Intern Med. 1967 Aug;67(2):291–302. doi: 10.7326/0003-4819-67-2-291. [DOI] [PubMed] [Google Scholar]
  9. Cochrane C. G., Müller-Eberhard H. J., Aikin B. S. Depletion of plasma complement in vivo by a protein of cobra venom: its effect on various immunologic reactions. J Immunol. 1970 Jul;105(1):55–69. [PubMed] [Google Scholar]
  10. Dale D. C., Reynolds H. Y., Pennington J. E., Elin R. J., Herzig G. P. Experimental Pseudomonas pneumonia in leukopenic dogs: comparison of therapy with antibiotics and granulocyte transfusions. Blood. 1976 May;47(5):869–876. [PubMed] [Google Scholar]
  11. Edwards M., Stark J. M. The ability of smooth and rough strains of Streptococcus pneumoniae to activate human complement by the alternative pathway. J Med Microbiol. 1978 Feb;11(1):7–14. doi: 10.1099/00222615-11-1-7. [DOI] [PubMed] [Google Scholar]
  12. Ehlenberger A. G., Nussenzweig V. The role of membrane receptors for C3b and C3d in phagocytosis. J Exp Med. 1977 Feb 1;145(2):357–371. doi: 10.1084/jem.145.2.357. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Feld R., Bodey G. P. Infections in patients with malignant lymphoma treated with combination chemotherapy. Cancer. 1977 Mar;39(3):1018–1025. doi: 10.1002/1097-0142(197703)39:3<1018::aid-cncr2820390304>3.0.co;2-n. [DOI] [PubMed] [Google Scholar]
  14. Folland D., Armstrong D., Seides S., Blevins A. Pneumococcal bacteremia in patients with neoplastic disease. Cancer. 1974 Mar;33(3):845–849. doi: 10.1002/1097-0142(197403)33:3<845::aid-cncr2820330333>3.0.co;2-6. [DOI] [PubMed] [Google Scholar]
  15. Gaya H., Tattersall M. H., Hutchinson R. M., Spiers A. S. Changing patterns of infection in cancer patients. Eur J Cancer. 1973 Jun;9(6):401–406. doi: 10.1016/0014-2964(73)90104-7. [DOI] [PubMed] [Google Scholar]
  16. Gross G. N., Rehm S. R., Pierce A. K. The effect of complement depletion on lung clearance of bacteria. J Clin Invest. 1978 Aug;62(2):373–378. doi: 10.1172/JCI109138. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Inagaki J., Rodriguez V., Bodey G. P. Proceedings: Causes of death in cancer patients. Cancer. 1974 Feb;33(2):568–573. doi: 10.1002/1097-0142(197402)33:2<568::aid-cncr2820330236>3.0.co;2-2. [DOI] [PubMed] [Google Scholar]
  18. Klastersky J., Weerts D. Recent experience with bacteremia in patients presenting cancer. Eur J Cancer. 1973 Jan;9(1):69–76. doi: 10.1016/0014-2964(73)90045-5. [DOI] [PubMed] [Google Scholar]
  19. Kourounakis L., Nelson R. A., Jr, Kupusta M. A. The effect of a cobra venom factor on complement and adjuvant-induced disease in rats. Arthritis Rheum. 1973 Jan-Feb;16(1):71–76. doi: 10.1002/art.1780160111. [DOI] [PubMed] [Google Scholar]
  20. Lay W. H., Nussenzweig V. Receptors for complement of leukocytes. J Exp Med. 1968 Nov 1;128(5):991–1009. doi: 10.1084/jem.128.5.991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Lehane D. E., Lane M. Immunocompetence in advanced cancer patients prior to chemotherapy. Oncology. 1974;30(6):458–466. doi: 10.1159/000224989. [DOI] [PubMed] [Google Scholar]
  22. Middleman E. L., Watanabe A., Kaizer H., Bodey G. P. Antibiotic combinations for infections in neutropenic patients. Evaluaton of carbenicillin plus either cephalothin or kanamycin. Cancer. 1972 Aug;30(2):573–579. doi: 10.1002/1097-0142(197208)30:2<573::aid-cncr2820300238>3.0.co;2-o. [DOI] [PubMed] [Google Scholar]
  23. Pepys M. B. Studies in vivo of cobra factor and murine C3. Immunology. 1975 Feb;28(2):369–377. [PMC free article] [PubMed] [Google Scholar]
  24. Reed W. P., Davidson M. S., Williams R. C., Jr Complement system in pneumococcal infections. Infect Immun. 1976 Apr;13(4):1120–1125. doi: 10.1128/iai.13.4.1120-1125.1976. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Rosner F., Valmont I., Kozinn P. J., Caroline L. Leukocyte function in patients with leukemia. Cancer. 1970 Apr;25(4):835–842. doi: 10.1002/1097-0142(197004)25:4<835::aid-cncr2820250412>3.0.co;2-#. [DOI] [PubMed] [Google Scholar]
  26. SMITH M. R., WOOD W. B., Jr An experimental analysis of the curative action of penicillin in acute bacterial infections. II. The role of phagocytic cells in the process of recovery. J Exp Med. 1956 Apr 1;103(4):499–508. doi: 10.1084/jem.103.4.499. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Scott R. E., Robson H. G. Synergistic activity of carbenicillin and gentamicin in experimental Pseudomonas bacteremia in neutropenic rats. Antimicrob Agents Chemother. 1976 Oct;10(4):646–651. doi: 10.1128/aac.10.4.646. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Shin H. S., Smith M. R., Wood W. B., Jr Heat labile opsonins to pneumococcus. II. Involvement of C3 and C5. J Exp Med. 1969 Dec 1;130(6):1229–1241. doi: 10.1084/jem.130.6.1229. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Sickles E. A., Young V. M., Greene W. H., Wiernik P. H. Pneumonia in acute leukemia. Ann Intern Med. 1973 Oct;79(4):528–534. doi: 10.7326/0003-4819-79-4-528. [DOI] [PubMed] [Google Scholar]
  30. Smith M. R., Shin H. S., Wood W. B., Jr Natural immunity to bacterial infections: the relation of complement to heat-labile opsonins. Proc Natl Acad Sci U S A. 1969 Aug;63(4):1151–1156. doi: 10.1073/pnas.63.4.1151. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Smith M. R., Wood W. B., Jr Heat labile opsonins to pneumococcus. I. Participation of complement. J Exp Med. 1969 Dec 1;130(6):1209–1227. doi: 10.1084/jem.130.6.1209. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Stephens C. G., Williams R. C., Jr, Reed W. P. Classical and alternative complement pathway activation by pneumococci. Infect Immun. 1977 Aug;17(2):296–302. doi: 10.1128/iai.17.2.296-302.1977. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Trnka L., Kvapilová M., Mison P. Influence of immunosuppression on the action of antimycobacterial drugs in experimental tuberculosis. I. Effects of isoniazid, rifampicin and streptomycin on the survival of tuberculous mice immunosuppressed by azathioprine (Imuran). Chemotherapy. 1976;22(6):353–361. doi: 10.1159/000221947. [DOI] [PubMed] [Google Scholar]
  34. ULTMANN J. E., FISH W., OSSERMAN E., GELLHORN A. The clinical implications of hypogammaglobul inemia in patients with chronic lymphocytic leukemia and lymphocytic lymphosarcoma. Ann Intern Med. 1959 Sep;51:501–516. doi: 10.7326/0003-4819-51-3-501. [DOI] [PubMed] [Google Scholar]
  35. WOOD W. B., SMITH M. R. Host-parasite relationships in experimental pneumonia due to pneumococcus type III. J Exp Med. 1950 Jul 1;92(1):85–100. doi: 10.1084/jem.92.1.85. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Winkelstein J. A., Shin H. S., Wood W. B., Jr Heat labile opsonins to Pneumococcus. 3. The participation of immunoglobulin and of the alternate pathway of C3 activation. J Immunol. 1972 Jun;108(6):1681–1689. [PubMed] [Google Scholar]
  37. Winkelstein J. A., Smith M. R., Shin H. S. The role of C3 as an opsonin in the early stages of infection. Proc Soc Exp Biol Med. 1975 Jun;149(2):397–401. doi: 10.3181/00379727-149-38815. [DOI] [PubMed] [Google Scholar]
  38. Winkelstein J. A., Swift A. J. Host defense against the pneumococcus in T-lymphocyte-deficient, nude mice. Infect Immun. 1975 Nov;12(5):1222–1223. doi: 10.1128/iai.12.5.1222-1223.1975. [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. Winkelstein J. A., Tomasz A. Activation of the alternative pathway by pneumococcal cell walls. J Immunol. 1977 Feb;118(2):451–454. [PubMed] [Google Scholar]

Articles from Infection and Immunity are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES